Atlas Trials

A Study of the Effect of Vemurafenib on the Pharmacokinetics of Phenprocoumon in Patients With BRAFV600 Mutation-Positive Metastatic Malignancy

Clinical trial NCT01849666 · COMPLETED

Trial details

NCT number
NCT01849666
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Malignant Melanoma, Neoplasms
Start date
2013-09-01
Primary completion
2014-04-01
Enrollment
2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.